Report cover image

Clinical Trial Support Services Market by Service (Administrative Staff, Clinical Trial Site Management, Data Management), Phase (Phase I, Phase II, Phase III), Study Design, Indication, Sponsor - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 192 Pages
SKU # IRE18437200

Description

Clinical Trial Support Services Market by Service (Administrative Staff, Clinical Trial Site Management, Data Management), Phase (Phase I, Phase II, Phase III), Study Design, Indication, Sponsor - Global Forecast 2024-2030


The Clinical Trial Support Services Market size was estimated at USD 23.98 billion in 2023 and expected to reach USD 26.19 billion in 2024, at a CAGR 9.59% to reach USD 45.54 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Support Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Support Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Support Services Market, highlighting leading vendors and their innovative profiles. These include Alcura, Brighter Health Network LLC, Charles River Laboratories International, Inc., Eli Lilly and Company, Eurofins Scientific SE, ICON PLC, Insight Medical Genetics, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, MARKEN Ltd., Parexel International, Pfizer Inc., PPD Inc., Quotient Sciences Ltd., Syneos Health Inc., and WuXi AppTec.

Market Segmentation & Coverage


This research report categorizes the Clinical Trial Support Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

Service
Administrative Staff
Clinical Trial Site Management
Patient Recruitment & Registry Services

Patient Recruitment Management

Patient Retention
Data Management
Institutional Review Boards
Phase
Phase I
Phase II
Phase III
Phase IV
Study Design
Expanded Access
Interventional
Observational
Indication
Autoimmune or Inflammation
Cardiovascular
Diabetes
Oncology
Sponsor
Medical Devices
Pharmaceutical & Biopharmaceutical
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Support Services Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Support Services Market?
3. What are the technology trends and regulatory frameworks in the Clinical Trial Support Services Market?
4. What is the market share of the leading vendors in the Clinical Trial Support Services Market?
5. Which modes and strategic moves are suitable for entering the Clinical Trial Support Services Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

192 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Trial Support Services Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases coupled with increasing number of clinical trials
5.1.1.2. Government grants for clinical trials
5.1.1.3. Increasing number of contract research organizations
5.1.2. Restraints
5.1.2.1. Stringent regulatory compliance for clinical trials
5.1.3. Opportunities
5.1.3.1. Rising industry-academia collaborations
5.1.3.2. R&D spending of pharmaceutical & biotechnology companies
5.1.4. Challenges
5.1.4.1. Limited supportive infrastructure in low income economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Clinical Trial Support Services Market, by Service
6.1. Introduction
6.2. Administrative Staff
6.3. Clinical Trial Site Management
6.4.1. Patient Recruitment & Registry Services
6.4.2. Patient Recruitment Management
6.4.3. Patient Retention
6.4. Data Management
6.5. Institutional Review Boards
7. Clinical Trial Support Services Market, by Phase
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
8. Clinical Trial Support Services Market, by Study Design
8.1. Introduction
8.2. Expanded Access
8.3. Interventional
8.4. Observational
9. Clinical Trial Support Services Market, by Indication
9.1. Introduction
9.2. Autoimmune or Inflammation
9.3. Cardiovascular
9.4. Diabetes
9.5. Oncology
10. Clinical Trial Support Services Market, by Sponsor
10.1. Introduction
10.2. Medical Devices
10.3. Pharmaceutical & Biopharmaceutical
11. Americas Clinical Trial Support Services Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Trial Support Services Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Trial Support Services Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Alcura
15.1.2. Brighter Health Network LLC
15.1.3. Charles River Laboratories International, Inc.
15.1.4. Eli Lilly and Company
15.1.5. Eurofins Scientific SE
15.1.6. ICON PLC
15.1.7. Insight Medical Genetics
15.1.8. IQVIA Holdings Inc.
15.1.9. Laboratory Corporation of America Holdings
15.1.10. MARKEN Ltd.
15.1.11. Parexel International
15.1.12. Pfizer Inc.
15.1.13. PPD Inc.
15.1.14. Quotient Sciences Ltd.
15.1.15. Syneos Health Inc.
15.1.16. WuXi AppTec
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. CLINICAL TRIAL SUPPORT SERVICES MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIAL SUPPORT SERVICES MARKET DYNAMICS
FIGURE 7. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 8. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 10. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY STUDY DESIGN, 2023 VS 2030 (%)
FIGURE 12. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY STUDY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 14. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY SPONSOR, 2023 VS 2030 (%)
FIGURE 16. CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY SPONSOR, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CLINICAL TRIAL SUPPORT SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. CLINICAL TRIAL SUPPORT SERVICES MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us